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Abstract
Lentinula edodes (shiitake), an edible and medicinal mushroom, was chosen for this study with the aim of evaluating the
possibility of release of bioelements into artificial digestive juices and analyzing the anti-inflammatory properties. The extracts
were prepared from fruiting bodies and biomass enriched with copper (Cu), zinc (Zn), and selenium (Se). The content of
bioelements was analyzed by total reflection X-ray fluorescence method. Relatively low content of elements was observed in
the fruiting bodies: Cu–1.6, Zn–7.6, and Se–0.12mg/100 g d.w. compared tomycelial cultures. The anti-inflammatory properties
were evaluated in RAW 264.7 cells. Based on the levels of cyclooxygenase 2 protein, nuclear factor erythroid 2-related factor 2,
and peroxisome proliferator-activated receptor γ determined using Western blot technique, it was found that the addition of
bioelements enhanced the anti-inflammatory properties of mycelium. This indicates that L. edodes cultured on a suitable medium
may be used as a potential component of anti-inflammatory products.
Keywords Shiitake . Biologically active elements . Extraction in digestive juices . Medicinal properties of mushrooms . RAW
264.7 cells
Introduction
Lentinula edodes (Berk.) Pegler (Basidiomycota), known as
shiitake, is the second most popular species of edible mush-
room next to Agaricus bisporus (J.E. Lange) Imbach (white
mushroom) and is obtained by cultivation. The fruiting bodies
of L. edodes are of both dietary and therapeutic significance,
and hence, this species is listed as one of the medicinal mush-
rooms [1–3]. This species owes its popularity to its culinary
uses, but above all to the presence of substances with thera-
peutic properties. The drugs and other medicinal products ob-
tained from L. edodes are used in the treatment of various
cancers due to their immunostimulating, anti-inflammatory,
and anti-oxidant effects [1, 2, 4, 5]. The polysaccharides pres-
ent in the fruiting bodies of L. edodes enhance the immune
function and eliminate the side effects of chemo- and radio-
therapy, besides exhibiting anti-cancer, anti-viral, and anti-
bacterial properties. The compounds responsible for the bio-
logical activity of L. edodes are the polysaccharides belonging
to the group of β-D-glucans, which include lentinan [3–9].
Other important antibiotic substances identified in the fruiting
bodies of L. edodes are lentin (protein), lenthionine
(exobiopolymer containing sulfur in the molecule), lentinosin
(purine compound), and lentinamycin A and B [1]. In 1972,
atherosclerotic substances, the most important of which are
statins including eritadenine and lovastatin, were also detected
in the fruiting bodies of L. edodes [6, 8, 9]. Like other mush-
room species, the fruiting bodies of L. edodes are a good
source of vitamins and have the ability to accumulate
bioelements [1, 2, 5, 8]. Because elements such as copper
(Cu), zinc (Zn), and selenium (Se) were detected in the
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fruiting bodies of L. edodes, which play a key role as anti-
inflammatory factors, this study was undertaken to obtain bio-
mass from the in vitro cultures of L. edodes with maximum
content of Cu(II), Zn(II), and Se(IV) ions [2, 10–12].
The aim of this study was to investigate whether modifying
the composition of the medium used for in vitro culturing of
L. edodes will allow obtaining biomass rich in bioelements
that may be used as a potential component in natural anti-
inflammatory products.
The study also aimed to analyze whether the elements
added to the culture media were accumulated in higher
amounts by mycelium and were then released into artificial
digestive juices in a Gastroel-2014 apparatus which is espe-
cially designed for this purpose [13]. It was checked whether
the bioelements were released effectively under conditions
imitating those prevailing in the human gastrointestinal tract,
which could be reflected in their protective effects on the
mucous membranes of the stomach and intestines.
The content of Cu, Zn, Se, calcium (Ca), potassium (K),
iron (Fe), and manganese (Mn) was determined in mushroom
materials. The content of the released bioelements was evalu-
ated by total reflection X-ray fluorescence (TXRF) method.
The study also aimed to determine which of the bioelements
(Cu, Zn, Se) is the most beneficial to obtain mycelium with a
higher anti-inflammatory potential, using RAW 264.7 cell
lines (mouse macrophages) activated with lipopolysaccharide
(LPS).
Materials and Methods
Reagents
The substances used to mineralization process: HNO3 (65%)
and H2O2 (30%) (Suprapur®) were obtained from Merck
(Darmstadt, Germany). Four-time distilled water with conduc-
tivity below 1 μS/cm was obtained in HLP 5 apparatus from
Hydrolab (Straszyn, Poland).
Additives for mushroom media in the form of copper sul-
fate (CuSO4) and zinc sulfate (ZnSO4) were purchased from
the Polish Company of Chemistry (Gliwice, Poland). Zinc
hydrogen aspartate (C8H12N2O8Zn) and copper gluconate
(C12H22CuO14) were purchased from Farmapol (Poznań,
Poland). Selenitriglycerides (Selol)—prepared from Se(IV)
and sunflower oil—was obtained from the Department of
Bioanalysis and Drug Analysis at the Medical University of
Warsaw in the synthesis process as described in Polish patent
76,530 [14]. Selol was used with a declared Se concentration
of 5% (w/v).
The substances used to prepare artificial digestive juices
were purchased from different companies: CaCl2 and MgCl2
from Chempur (Kraków, Poland); NaHCO3 from PPH
Golpharm (Kraków, Poland); NaCl and NH4Cl from Alfa
Aesar® (Kandel, Germany); bile salts and pepsin from BTL
(Łódź, Poland); pancreatic extract and HCl Suprapur® from
Merck (Darmstad, Germany); and KHCO3, C6H8O7,
Na2HPO4, and K2HPO4 from Polish Company of Chemistry
(Gliwice, Poland).
Materials
Fresh fruiting bodies of L. edodes species of commercial ori-
gin were used for the experiments and for establishing in vitro
cultures. The young fruiting bodies were taxonomically iden-
tified using the MycoKey 4.1 key (http://www.mycokey.
com). Mycelial fragments were collected from the hymenial
part of fresh fruiting bodies and were degreased with 70%
ethyl alcohol. The fragments were then sterilized with 15%
sodium hypochlorite (NaClO) solution for several minutes.
After rinsing with redistilled water, sterile fragments of
fruiting bodies were transferred under laminar flow to
Oddoux medium solidified with agar [15]. To obtain a large
amount of biomass, it is necessary that the biomass grown on
in vitro cultures on solid medium be transferred to a modified
Oddoux liquid substrate. Therefore, biomass obtained from
in vitro cultures on solid medium was transferred to
Erlenmeyer flasks containing 250 mL of liquid medium; the
initial mass of the inoculum was 0.1 g. The in vitro cultures
were allowed to grow for 21 days on Oddoux medium at 25 ±
2 °C, under a photoperiod of 16 h light (900 lx) and 8 h dark,
on an ALTEL shaker (Poland) at 140 rpm.
Experimental In Vitro Cultures of L. edodes
The following materials were prepared for the planned exper-
iments: biomass of L. edodes (control) was obtained on a
liquid Oddoux medium and on the same liquid medium with
the addition of zinc compounds, such as zinc hydrogen aspar-
tate (C8H12N2O8Zn) at a concentration of 200 mg/L and zinc
sulfate (ZnSO4) at a concentration of 174.47mg/L, and copper
compounds, such as copper gluconate (C12H22CuO14) at a
concentration of 72.88 mg/L and copper sulfate (CuSO4) at
a concentration of 33.60 mg/L. In vitro cultures of L. edodes
were prepared on a medium enriched with Se organic com-
pounds too by the addition of Selol (Se(IV) 25 and 50 mg/L
medium). The mycelial cultures were transferred to
Erlenmeyer flasks and were shaken in order to promote a high
growth of biomass. After culturing, mycelium was separated
from the medium, frozen, and lyophilized (Freezone 4.5
lyophilizator, Labonco; temperature − 40 °C) for further ex-
periments as in previous study [16, 17].
Analysis of Bioelements in L. edodes Mycelium
The amount of elements in the fruiting bodies and mycelium
of L. edodes and extracts obtained by digestion with artificial
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digestive juices was determined using TXRF method. The
TXRF method was chosen for this study due to several sig-
nificant aspects, such as high sensitivity, precision, accuracy,
and repeatability of analyses, as well as possibility to achieve
faster measurement with a very large number of samples. The
optimization of mineralization conditions for analysis of sam-
ples in combination with the TXRF method enabled optimal
analysis of bioelements in the fruiting bodies, mycelial cul-
tures, and extracts obtained from L. edodes.
For this analysis, 0.2 g samples of lyophilized mushroom
material were weighed, with an accuracy of 0.01 g, and were
transferred to Teflon vessels, to which 2 mL of H2O2 solution
(30%) and 4 mL of concentrated HNO3 solution (65%) were
added. Mineralization was carried out in Magnum II micro-
wave apparatus (ERTEC) in three stages of 10 min each, at a
power of 70% and 100%, respectively, maintaining the tem-
perature of the device at 290 °C. After mineralization, the
solutions were transferred to quartz evaporators and evaporat-
ed on a heating plate at 150 °C to remove excess reagents and
water. The residue obtained after evaporation was quantita-
tively transferred to 10-mL volumetric flasks with four-time
distilled water. To analyze the composition of bioelements
such as K, Ca, Mn, Fe, Cu, Zn, and Se in the prepared test
samples, 1000 ppm gallium was used as an internal standard.
The composition of elements was measured using a TXRF
spectrometer Nanohunter II (Rigaku) equipped with an X-
ray tube containing a molybdenum anode at 50 kV for 1000 s.
Artificial Digestive Juice Extraction
Artificial digestive juices imitating saliva, gastric and intesti-
nal juices were used in the study to extract the bioelements
from L. edodes mycelium. These digestive juices were pre-
pared as follows:
Artificial Saliva Solutions of 100 mL MgCl2 (1.5 mmol/L),
100 mL KH2PO4 (25 mmol/L) , 100 mL KHCO3
(150 mmol/L), 100 mL Na2HPO4 (24 mmol/L), 6 mL citric
acid (25 mmol/L), and 100 mL CaCl2 (15 mmol/L) were pre-
pared and added successively to a volumetric flask. The vol-
ume of the solution was made up to 1000 mL with four-time
distilled water [18].
Artificial Gastric Juice A total of 3.2 g of pepsin and 2.0 g of
NaCl were dissolved in four-time distilled water, and then to
this solution, 80 mL of 1 mol/L HCl was added. The volume
of the solution was finally made up to 1000 mL with water
[19].
Artificial Intestinal Juice A total of 120 mg bile acids, 20 mg
pancreatic extract, and 8.4 g NaHCO3 were dissolved in four-
time distilled water, and the volume of the solution was made
up to 1000 mL with water [20].
Extracts were obtained from lyophilized biomass from
fruiting bodies and in vitro cultures of L. edodes and were
digested in vitro using artificial digestive juices in the
Gastroel-2014 apparatus as follows [13]. The extraction of
mushroommaterial was carried out under conditions imitating
those prevailing in the human body (temperature 37 °C and
mixing movements imitating peristaltic movements). About
0.3 g of mushroom material was transferred to 100-mL
Erlenmeyer flasks and moistened with 3 mL of artificial saliva
solution for 1 min. Then, 20 mL of gastric juice was added to
the flasks. The flasks were sealed and placed in the Gastroel-
2014 apparatus for the digestion process. The process was
conducted for 30 and 60 min, respectively. The obtained ex-
tracts were filtered using of paper filters and syringe mem-
brane filters. The remaining mushroom material was again
transferred to Erlenmeyer flasks, and 20 mL of intestinal juice
was added. Digestion was allowed to proceed for 150 min.
After digestion, the extracts were filtered to obtain a clear
solution. Each sample was subjected to three independent rep-
etitions. The content of elements was also determined by
TXRF method described above.
Preparation of Mycelial Extracts for Evaluation
of Anti-inflammatory Properties
To prepare methanolic extracts of L. edodes, the lyophilized
biomass obtained from in vitro cultures was first homogenized
in a mortar, and 2 g of each homogenate sample was then used
for extraction. Mycelium was extracted five times with
100 mL of methanol using ultrasound at a frequency of
49 kHz for 30 min (Sonic-2, Polsonic, Poland). Following
extraction, the methanol in the extracts was evaporated to
dryness. Then, 250 mg of dry extract was dissolved in 96%
ethanol, filtered through sterile bacteriological syringe filters
with a pore diameter of 0.2 μm, and transferred quantitatively
to 5-mL volumetric flasks. The prepared samples were then
diluted to the desired concentrations by mixing 100 μL with
900 μL of distilled water. Finally, the extracts were stored at
4 °C until they were used for analysis of anti-inflammatory
activity in RAW 264.7 cell lines.
Cell Cultures
Musmusculusmacrophages RAW264.7 (American Type Cell
Culture: TIB-71) were cultured in Dulbecco’s modified
Eagle’s medium supplemented with 1% antibiotic solution
(100 IU/mL penicillin, 0.1 μg/mL streptomycin) and 10%
fetal bovine serum (ATCC, Manassas, VA, USA). The cells
were maintained in a humidified atmosphere with 5% CO2 in
air at 37 °C and were finally seeded into a six-well plate
(Sarstedt AG&Co., Nümbrecht, Germany) at a density of
5 × 105 cells/well in 2 mL of medium. Before the experiment,
the morphology of cells was observed with an inverted light
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microscope (Olympus, Tokyo, Japan), and cell viability was
assessed by Trypan Blue Exclusion Test. Then, cells were
activated with LPS (10 ng/mL) and incubated with the pre-
pared mushroom extracts (100 μL) for 24 h.
No cytotoxic effects or apoptosis were observed in the
RAW 264.7 cells activated with LPS and treated with
L. edodes extracts. Cell viability varied from 100 to 99% fol-
lowing treatment with the extracts. After incubation, both the
media and the cells were collected by scrapping.
Western Blot for Protein Quantification
Cell lysates were prepared using M-PER (Thermo Fisher
Scientific, Waltham, MA, USA) buffer with protease inhibitor
cocktail set III (Merck, Darmstadt, Germany). The contents of
proteins in the lysates were determined using Bradford reac-
tion. Samples (40 μg) were solubilized in Laemmli buffer
added with 2% mercaptoethanol (Bio-Rad, Hercules, CA,
USA) and were then subjected to 10% SDS (sodium dodecyl
sulfate)-polyacrylamide gel electrophoresis as described earli-
er [21]. Following transfer, membranes were blocked for 1 h at
room temperature in the presence of casein in TBS (tris-buff-
ered saline)–1% Tween buffer (Bio-Rad) and subsequently
incubated overnight at 4 °C with the following primary anti-
bodies: anti-COX-2, anti-Nrf2, anti-FABP4, anti-β-actin
(GeneTex Inc., Irvine, CA, USA), and anti-PPARγ (Cayman
Chemical, Ann Arbor, MI, USA), all of which were diluted to
the ratio of 1:1000. After incubation, the membranes were
washed and incubated with secondary antibodies (anti-rabbit
IgG (HRP); Thermo Fisher Scientific, Waltham, MA, USA)
for 1 h at room temperature. Then, the membranes were
washed again, and proteins were detected using a Clarity
Western ECL Luminol Substrate detection kit (Bio-Rad).
The integrated optical density of the protein bands was quan-
tified using a Chemi Doc Camera with Image Lab software
(Bio-Rad).
Statistical Analysis
The results are shown as mean ± standard deviation (SD), and
all experiments were performed six times. Using one-way
ANOVA with Tukey’s test was used to elaborate the results
of evaluation of bioelements composition as well as proteins
level. For all the tests, the value p < 0.05 was accepted as the
level of statistical significance (GraphPad InStat).
Results and Discussion
The amount of biomass obtained from L. edodes mycelium
cultures grown on control media was 8–9 g d.w. (dry weight)/
L medium, whereas the amount obtained frommedia enriched
with bioelements (Cu, Se, Zn) was 9–9.5 g. The dynamics of
mycelium growth did not differ from that reported in the ear-
lier studies [16, 22].
In the first stage of the study, the content of selected macro-
(K, Ca) and microelements (Mn, Fe, Cu, Zn, Se) in the fruiting
bodies of L. edodes of commercial origin was determined, as
well as those present in the mycelium of L. edodes obtained
from in vitro cultures grown on modified liquid media, which
were enriched with Cu, Zn, and Se compounds in inorganic
(ZnSO4, CuSO4) and organic forms (C8H12N2O8Zn,
C12H22CuO14, and Selol) (Table 1). It is well known that
mushroom extracts exhibit anti-inflammatory properties;
therefore, the bioelements that also exert similar effects were
chosen for fortification of in vitro cultures [5, 22]. As a result,
myceliumwith the highest possible anti-inflammatory activity
was obtained.
Among all the elements, K was found at the highest content
in the fruiting bodies; its content was 1839.5 mg/100 g d.w.
The content of Ca was highest in the mycelium cultured on the
control medium; its content was 684.4 mg/100 g d.w. The
presented results from the analysis of macroelement content
in L. edodes mycelium were higher compared to the results
obtained for fruiting bodies of the same species (K 537.9–
1031.0 mg/100 g d.w., Ca 17.9–60.7 mg/100 g d.w.)
[23–26]. The content of Cu was 21.0 mg/100 g d.w. in the
mycelium obtained on the medium enriched with CuSO4,
whereas the content of Fe was 14.6 mg/100 g d.w. in the
mycelium obtained on the medium enriched with
C12H22CuO14. The highest content of Mn, 18.9 mg/100 g
d.w., was found in the mycelium obtained from non-
enriched medium. In the case of Se, an amount of 568.6 mg/
100 g d.w. was found in the mycelium obtained on the medi-
um enriched with Selol at a higher concentration (Se(IV)
50 mg/L medium). A high amount of Zn (231.2 mg/100 g
d.w.) was found in the mycelium obtained from in vitro cul-
tures enriched with ZnSO4 (Table 1). Analysis of
micronutrients showed that obtained L. edodes mycelia were
characterized by a higher content of these elements than
fruiting bodies of this mushroom species (Mn 0.2–4.8 mg/
100 g d.w., Fe 4.4–12.5 mg/100 g d.w., Cu 1.4–18.2 mg/
100 g d.w., Zn 5.9–28.4 mg/100 g d.w.) [23–26].
Because Zn, Cu, and Se, which are the elements with a high
anti-inflammatory potential, were added to the culture medi-
um, their content in mycelial cultures was analyzed in the next
stage of the study, with respect to the type of compound and
concentration used [5].
It was identified that the amount of Cu was highest
(21.0 mg/100 g d.w.) in the biomass of L. edodes cultured
on the medium enriched with inorganic copper salt (CuSO4),
while a slightly lesser amount was found in the mycelium
obtained from in vitro cultures grown on the media enriched
with C12H22CuO14 (20.4 mg/100 g d.w.). A similar trend was
observed for the content of Zn: the amount of Zn in the bio-
mass of L. edodes obtained on the medium enriched with
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inorganic salt (ZnSO4) was 231.2 mg/100 g d.w., which was
almost twice as high as the amount in the mycelium obtained
from in vitro cultures grown on the medium enriched with
C8H12N2O8Zn (141.2 mg/100 g d.w.). Selenium was added
to the medium only in organic form due to its proven benefi-
cial effect on the human body compared to the classic sodium
selenite (Na2SO3) with a very narrow therapeutic index [12].
The highest amount of Se was obtained from the medium
added with the highest dose of Se (568.6 mg/100 g d.w.).
Because the elements Cu, Zn, and Se were identified in bio-
mass obtained from in vitro cultures grown on medium
enriched with these elements, a particularly valuable property
of edible mushroom mycelia, i.e., their natural ability to accu-
mulate elements from the medium on which they grow, was
confirmed (Table 1) [16, 17, 26]. Therefore, mushroom
mycelia can be successfully used as a natural source of these
elements.
In order to determine the actual bioavailability of Cu, Zn,
and Se to the human body, the release of these elements from
the mushroom material into artificial digestive juices was in-
vestigated. Selenium is an essential micronutrient for human,
and its deficiency causes harmful effects in living organisms,
not only the amount of Zn and Cu released from the fruiting
bodies andmycelium obtained from in vitro cultures grown on
medium enriched with Zn and Cu salts, but also the amount of
Se released from mycelium grown on medium enriched with
Selol was evaluated [12]. The evaluation of the effect of ad-
dition of Se(IV) compounds on the amount of Cu and Zn
released from mycelial cultures of L. edodes was also useful
in the analysis of anti-inflammatory activity.
It was confirmed from the experiments that the tested
bioelements were effectively released into artificial digestive
juices. Thus, these elements may also be bioavailable for the
human body (Fig. 1a–f). The previous experiments also pre-
sented that the elements from mushroom materials were re-
leased effectively [16, 17, 27].
The study showed that the examined elements were re-
leased in larger amounts into gastric juice than into intestinal
juice, and to a small extent, the amount of elements released
was dependent on the duration of the extraction process. The
same trends were observed for the Imleria badia mycelium
[16]. In the case of Zn, the amount released in artificial gastric
juice from the biomass grown on the medium enriched with
ZnSO4 was determined to be 22.73mg/100 g d.w. after 30min
of incubation and 32.46 mg/100 g d.w. after 60 min of incu-
bation. When extracted into intestinal juice, the amounts re-
leased were lower and equaled to 0.77 and 1.56 mg/100 g
d.w., respectively. In the case of mycelium enriched with
C8H12N2O8Zn, the amount of Zn released into gastric juice
after 30 min was 13.2 mg/100 g d.w. and after 60 min was
10.3 mg/100 g d.w., and the amount released into intestinal
juice was about 1 mg/100 g d.w. In the case of mycelium
grown on the control medium, the amount of Zn released into
artificial gastric juice was 0.4 mg/100 g d.w. In the case of Zn
released into artificial intestinal juice, the amounts were found
to be below the level of quantification (Fig. 1a, d). Thus, the
results obtained confirmed the ability of the mycelium to ac-
cumulate Zn from the medium [16, 17].What is important, the
amounts of Zn released into the artificial gastric juice were
higher than those determined in the artificial intestinal juice.
This is in line with previous experiments where higher
amounts of elements were released into gastric juice [27].
Some differences were observed in the results of the analysis
of copper compounds. This element was more effectively re-
leased into artificial gastric juice after digestion of biomass
obtained on the medium enriched with organic copper salt
(C12H22CuO14). The content of Cu released into artificial gas-
tric juice was determined to be 11.91 mg/100 g d.w, whereas
the amount of Cu extracted into artificial intestinal juice was
only 3 mg/100 g d.w. (Fig. 1b, e). In the case of Se, it was
found that higher amounts (13.2 mg/100 g d.w.) were extract-
ed into artificial gastric juice from biomass obtained from
media enriched with Selol at higher concentration (Se(IV)
50 mg/L medium) than the amount (5.99 mg/100 g d.w.) ob-
tained with Selol at lower concentration (Se(IV) 25 mg/L me-
dium). The same tendency was observed in the analysis of Se
release into artificial intestinal juice (Fig. 1c, f).
Thus, the study on the release of Cu, Zn, and Se confirmed
that the fruiting bodies and mycelium of edible mushrooms
are the materials from which these elements are released into
artificial digestive juices and the released elements may po-
tentially be bioavailable to the human body. The obtained
results also corroborated that the biomass obtained from
in vitro cultures of L. edodes enriched with the
abovementioned microelements is a source of bioelements
which ensures an average supply of these elements to meet
the daily needs of the human body [28, 29].
The study also evaluated the anti-inflammatory activity of
mushroom extracts obtained from the in vitro cultures of
L. edodes grown on control media and the ones enriched with
Zn, Cu, and Se compounds. The results confirmed anti-
inflammatory activity of mushroom material (inflammation
was induced with a commonly used agent LPS) which was
in line with previous studies on edible mushroom species that
demonstrated their potential anti-inflammatory effect [5,
30–34].
Cyclooxygenase-2 (COX-2) is a pro-inflammatory protein,
and in the light of modern knowledge, searching for natural
COX-2 agonists is extremely important [32, 35–37]. The re-
sults of the present study showed statistically the highest level
of COX-2 in RAW 264.7 cells activated with LPS (p = 0.000).
A high expression of this protein was also recorded in cells
incubated with control mycelium extract activated with LPS
(Fig. 2a). Analysis of COX-2 level in macrophages treated
with L. edodes extracts from in vitro cultures grown on media
enriched with Cu, Zn, or Se compounds revealed that the
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expression of this protein was comparable to the control cells
despite cells activation with LPS. Similar results were ob-
served in the case of I. badia species, in which addition of
zinc salt to the medium had a positive effect on the anti-
inflammatory effect of mycelium compared to the control my-
celium [31]. In addition, it should be emphasized that the
mycelium obtained from cultures enriched with bioelements
(Cu, Zn, and Se) had a protective effect on the cells, reducing
their level of COX-2 in case of inflammation caused by LPS
(Fig. 2a). The results observed by other researchers in
Antrodia camphorata, Inonotus obliquus, A. bisporus,
Cantharellus cibarius, I. badia, Ganoderma lucidum, and
Elaphomyces granulates species showed that the signaling
pathway of COX-2 was inhibited [31, 38–42]. The present
study also revealed the anti-inflammatory properties of the
L. edodes extract enriched with vitamin D in C57B1/6 mouse
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Fig. 1 Amount (mg/100 g d.w.) of a Zn, b Cu, and c Se released into
artificial gastric juice and d Zn, e Cu, and f Se released into artificial
intestinal juice. Fruiting bodies—L. edodes fruiting bodies; Control—
L. edodes mycelium; ZnSO4—L. edodes mycelium enriched with
ZnSO4; ZnHasp—L. edodes mycelium enriched with C8H12N2O8Zn;
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model with inflammatory liver disease. Supplementation of
L. edodes extract with vitamin D resulted in a significant re-
duction of liver damage. In addition, the histopathological
features were improved and plasma levels of inflammatory
factors such as aminotransferases and interferon gamma
(INF-γ) were found to decrease. It was also noted that the
anti-inflammatory effect of mushroom extract and vitamin D
was synergistic in nature [6].
The study also analyzed Nrf2 (nuclear factor erythroid
2-related factor 2), a protein related to detoxification pro-
cesses and a transcription factor [43]. Activation of Nrf2
may lead to induction of phase II enzymes responsible for
inhibiting the activity of potential carcinogens. There is
also scientific evidence for the involvement of Nrf2 in
extinguishing inflammatory processes [35, 36]. In addi-
tion, a direct relationship between Nrf2 activity and
reduction of COX-2, which is a pro-inflammatory factor,
was identified [37]. Obtaining mycelium in laboratory
conditions, which can increase the activity of Nrf2, may
contribute to the development of new natural drugs with
anti-inflammatory potential in the future. Statistically, the
highest expression of Nrf2 was found in cells incubated
with control mycelial extracts (p = 0.000), in contrast to
LPS activated cells, where each enriched mycelial extracts
exhibited better anti-inflammatory activity (Fig. 2b).
Especially, high expression of Nrf2 was observed in
LPS-activated cells treated with mycelial extract enriched
with CuSO4 and C12H22CuO14 (Fig. 2b). Comparing with
the results obtained for another species, A. bisporus, it
was found tha t th i s spec ies a l so showed ant i -
inflammatory activity. The highest expression of Nrf2
was observed in cells treated with extracts from mycelial
Fig. 2 An exemplary blot and relative level of COX-2 (a), Nrf2 (b),
PPARγ (c), and FABP4 (d) in RAW 264.7 cells supplemented with
L. edodes mycelial extracts and activated with LPS. Vehicle—control
cells; LPS—cells activated with lipopolysaccharide; L. edodes—cells in-
cubated with extract from control mycelium; L. edodes+CuSO4—cells
incubated with extract enriched with CuSO4; L. edodes + CuGlu—cells
incubated with extract enriched with C12H22CuO14; L. edodes +
ZnSO4—cells incubated with extract enriched with ZnSO4; L. edodes +
ZnHasp—cells incubated with extract enriched with C8H12N2O8Zn;
L. edodes + Se—cells incubated with extract enriched with Se(IV)
50 mg/L medium. Values are presented as means ± SD. Data are
expressed as in relation to β-actin. *p < 0.001 relative to vehicle group,
#p < 0.001 relative to LPS-activated cells
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cultures of A. bisporus enriched with α-linolenic acid.
This suggests that mushroom extracts enriched with α-
linolenic acid may also upregulate Nrf2 signaling [44].
In addition, the results of an in vivo study conducted on
Antrodia cinnamomea showed the positive effect of this
mushroom species on the expression of Nrf2 [45].
However, the present study on L. edodes species showed
that mainly lentinan present in this species exerted an
anti-inflammatory effect, causing, inter alia, an increase
in Nrf2 expression [46].
In order to confirm the anti-inflammatory effect, the ex-
pression of the transcription factor peroxisome proliferator-
activated receptor γ (PPARγ) was also studied. PPARγ plays
an important role in the differentiation of adipocytes, in car-
bohydrate and lipid metabolism, and in the regulation of in-
flammatory processes. It has been proven that specific PPARγ
agonists can inhibit the development of insulin resistance
while acting simultaneously as anti-diabetic agents, and also
have beneficial effects on inflammatory diseases, and even on
some cancers [47, 48]. The relationship between the presence
of Zn as an anti-inflammatory agent and PPARγ activity was
also demonstrated [48]. In the present study, statistically, the
highest expression of PPARγ was observed in cells treated
with mushroom extracts enriched with CuSO4 after LPS acti-
vation (p = 0.000) and in cells treated with extracts enriched
with Selol without LPS activation (p = 0.01) (Fig. 2c).
However, it should be emphasized that the addition of each
mycelium extracts increased the level of PPARγ compared to
LPS-activated control cells (Fig. 2c). A study proved that diet
rich in fatty acids (FAs), especially edible mushrooms, may be
a factor affecting the level of PPARγ [32]. It also proved that
extracts from C. cibarius containing FAs exerted agonistic
activity against receptors activated by PPARγ [5]. In our
study, Western blot analysis of PPARγ level once again con-
firmed the anti-inflammatory effect of mushroom extracts.
Taking into account that edible mushrooms, including
L. edodes, show numerous pro-health activities due to the
presence of fatty acids (FAs), the expression of FA-binding
protein 4 (FABP4) was studied [5]. FABP4 is mainly found
in macrophages and adipose tissues, where it regulates the
storage of FAs and the lipolysis process. FABP4 is also an
important mediator of inflammation as well as a factor
responsible for metabolism [49]. An increase the expres-
sion of FABP4 was observed in the RAW 264.7 cells treat-
ed with mushroom extract, compared to macrophages ac-
tivated with LPS. The highest expression of this protein
was observed in cells without inflammatory state after
treatment with mushroom extracts enriched with CuSO4
again, while the lowest expression was observed in control
cells after LPS activation (Fig. 2d). Extracts enriched in
bioelements proved to be more effective than control my-
celial extracts (Fig. 2d). The following are some of the
saccharides in mushrooms that regulate FABP4 activity:
trehalose, β-glucans (e.g. lentinan from L. edodes species),
and chitosans [5].
Conclusion
The experiment joining the accumulation and release of the
examined bioelements into artificial digestive juices from
mushroom material, and also the analysis of their anti-
inflammatory properties, highlighted the potential benefits of
consumption of L. edodes species in the form of fruiting bod-
ies and biomass (being a potential dietary supplement). It was
presented that L. edodes in vitro cultures accumulated Cu, Zn,
and Se frommodified and optimized media and released them
effectively into artificial digestive juices, which can be direct-
ly translate into the expected results of digestion process in
human body. This indicates the possibility and benefits of
fortification of L. edodesmycelium with specific bioelements.
It was also demonstrated that the L. edodes species is char-
acterized by anti-inflammatory properties. From the results of
Western blot, it was found that addition of Cu, Zn, or Se
enhanced the anti-inflammatory properties of L. edodes my-
celial extracts, suggesting that the mycelium of L. edodesmay
be used as a potential component in natural anti-inflammatory
dietary supplement. Additionally, obtained results could be
used in commercial production of L. edodes.
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